Shopping Cart
- Remove All
- Your shopping cart is currently empty
PF-06843195 is a potent and selective PI3Kα inhibitor that binds to the active site of PI3Kα and prevents it from catalyzing the conversion of PIP2 to PIP3, thereby inhibiting the activation of AKT, with anti-tumor activity in vitro and in vivo.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $239 | In Stock |
Description | PF-06843195 is a potent and selective PI3Kα inhibitor that binds to the active site of PI3Kα and prevents it from catalyzing the conversion of PIP2 to PIP3, thereby inhibiting the activation of AKT, with anti-tumor activity in vitro and in vivo. |
Targets&IC50 | PI3Kδ:0.28 nM (Ki), PI3Kδ:160 nM (IC50, in Rat1 fibroblasts), PI3Kα:0.018 nM (Ki) |
In vitro | PF-06843195 is able to inhibit the proliferation of T47D and MCF7 cells with IC50 values of 32 nM and 62 nM, respectively. [1] |
In vivo | Methods: PF-06843195 (10 mg/kg, oral) and (2 mg/kg, intravenous) were used to treat rats and study its pharmacokinetics. Results: It showed excellent bioavailability (25%) after oral administration and high plasma clearance (30 mL/min/kg) and large distribution volume (3.0 L/kg) after intravenous injection. [1] |
Alias | PF06843195 |
Molecular Weight | 498.46 |
Formula | C20H25F3N8O4 |
Cas No. | 2067281-51-8 |
Smiles | N([C@]1(CO)CN(C(OCC(F)F)=O)CC1)C=2C(F)=C(N=C(N2)N3CCOCC3)C=4C=NC(N)=NC4 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50.00 mg/mL (100.31 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.